Direkt zum Inhalt
Merck
  • On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay.

On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay.

Analytical biochemistry (2017-02-09)
Voin Petrovic, Camilla Olaisen, Animesh Sharma, Anala Nepal, Steffen Bugge, Eirik Sundby, Bård Helge Hoff, Geir Slupphaug, Marit Otterlei
ZUSAMMENFASSUNG

The Multiplexed Inhibitor Bead (MIB) assay is a previously published quantitative proteomic MS-based approach to study cellular kinomes. A rather extensive procedure, need for multiple custom-made kinase inhibitors and an inability to re-use the MIB-columns, has limited its applicability. Here we present a modified MIB assay in which elution of bound proteins is facilitated by on-column trypsinization. We tested the modified MIB assay by analyzing extract from three human cancer cell lines treated with the cytotoxic drugs cisplatin or docetaxel. Using only three immobilized kinase inhibitors, we were able to detect about 6000 proteins, including ∼40% of the kinome, as well as other signaling, metabolic and structural proteins. The method is reproducible and the MIB-columns are re-usable without loss of performance. This makes the MIB assay a simple, affordable, and rapid assay for monitoring changes in cellular signaling.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Purvalanol B, ≥97% (HPLC), solid